Aug 2026
Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome.
BACKGROUND 22q11.2 deletion syndrome (22q11DS) confers a 20-30% lifetime risk of schizophrenia, with negative symptoms associated with poorer outcomes and higher psychosis risk. High rates of neurocognitive deficits, autism spectrum traits (ASD), and attention-deficit/hyperactivity disorder (ADHD) may further complicat...
David A. Parker, Marissa Chen, Elaine F. Walker et al.
· Schizophrenia Research · 0 citations